Discover 925 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 925
Brief Sleep Intervention for Bedtime Resistance
for
Child Sleep
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18+
Code: NCT06970392
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Portland OR, Vancouver, San Francisco CA, Calgary,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression
for
Acute Cannabis-induced CNS Depression
Location: Portland OR, Cincinnati OH, Worcester MA
Sponsor: Anebulo Pharmaceuticals
Sex: All
Age: 0+
Code: NCT06017622
Recruiting
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
for
Functional Hypothalamic Amenorrhea, FHA
Location: Portland OR, West Hills CA, Phoenix AZ, Erie PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18 - 40
Code: NCT07235917
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
for
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Location: Portland OR, Los Angeles CA, Oklahoma City OK,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07094087
Phase 3, Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
for
Aneurysm, Aneurysm, Intracranial
Location: Portland OR, Davis CA, Palo Alto CA, Los Angeles CA,
Sponsor: Stryker Neurovascular
Sex: All
Age: 18 - 70+
Code: NCT06872684
Recruiting
Insights in Endocervical Mucus Secretion
for
Cervical Mucus
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: Female
Age: 21 - 40
Code: NCT07111247
Recruiting
Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
for
Stillbirth, Placental Insufficiency
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: Female
Age: 15 - 50
Code: NCT07144839
Recruiting
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
for
Mitral Annular Calcification, Mitral Stenosis,
Location: Portland OR, San Francisco CA, Murray UT,
Sponsor: Mayra Guerrero
Sex: All
Age: 18+
Code: NCT04408430
Recruiting
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
for
Focal Seizures
Location: Portland OR, Seattle WA, Murray UT, La Jolla CA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT07233239
Phase 1, Recruiting
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Portland OR, Los Angeles CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06980038
Phase 2, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Portland OR, Sacramento CA, Stanford CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Portland OR, San Francisco CA, Salt Lake City UT,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence